本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Soleno Therapeutics

84.02
-1.7700-2.06%
盘后84.020.00000.00%17:07 EDT
成交量:103.57万
成交额:8,744.98万
市值:42.34亿
市盈率:-18.09
高:85.96
开:85.96
低:83.22
收:85.79
数据加载中...
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/28

SEC问询函

Form CORRESP - Correspondence
2023/10/23

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/16

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/11

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/10

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/06

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/04

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/29

重要事件披露

Form 8-K - Current report
2023/09/29

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/28

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/09/28

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses